BIOLASE (NASDAQ:BIOL) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of BIOLASE (NASDAQ:BIOL) in a report published on Thursday. The firm issued a sell rating on the medical technology company’s stock.

BIOLASE Price Performance

NASDAQ BIOL opened at $0.01 on Thursday. The firm has a market cap of $253,893.20, a PE ratio of 0.00 and a beta of 0.67. The stock’s 50 day simple moving average is $0.01 and its 200 day simple moving average is $0.02. BIOLASE has a one year low of $0.02 and a one year high of $1.94.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.